CDKN2A and breast cancer: Indeed, high expression of CDKN2A (p16) gene products, indicative of functional defects in RB1, has been described as a defining feature of basal-like breast cancers, and it has been suggested that this may represent an important early event in bypassing cellular stress and replicative senescence [23,24].